BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17437935)

  • 21. The risk of vector-borne infections in sled dogs associated with existing and new endemic areas in Poland. Part 2: Occurrence and control of babesiosis in a sled dog kennel during a 13-year-long period.
    Bajer A; Mierzejewska EJ; Rodo A; Welc-Falęciak R
    Vet Parasitol; 2014 May; 202(3-4):234-40. PubMed ID: 24612743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genotypically unique Babesia gibsoni-like parasite recovered from a dog in Oklahoma.
    Kocan AA; Kjemtrup A; Meinkoth J; Whitworth LC; Murphy GL; Decker L; Lorenz M
    J Parasitol; 2001 Apr; 87(2):437-8. PubMed ID: 11318581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intravenous pharmacokinetics of diminazene in healthy dogs.
    Naidoo V; Mulders MS; Swan GE
    J S Afr Vet Assoc; 2009 Dec; 80(4):215-9. PubMed ID: 20458860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and molecular characterization of a novel large Babesia species in a dog.
    Birkenheuer AJ; Neel J; Ruslander D; Levy MG; Breitschwerdt EB
    Vet Parasitol; 2004 Oct; 124(3-4):151-60. PubMed ID: 15381295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canine babesiosis caused by Babesia canis vogeli in rural areas of the State of Minas Gerais, Brazil and factors associated with its seroprevalence.
    Costa-Júnior LM; Ribeiro MF; Rembeck K; Rabelo EM; Zahler-Rinder M; Hirzmann J; Pfister K; Passos LM
    Res Vet Sci; 2009 Apr; 86(2):257-60. PubMed ID: 18723199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible emergence of drug-resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin.
    Sakuma M; Setoguchi A; Endo Y
    J Vet Intern Med; 2009; 23(3):493-8. PubMed ID: 19645835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiologic and clinical surveys in dogs infected with Babesia gibsoni in South Korea.
    Lee MJ; Yu DH; Yoon JS; Li YH; Lee JH; Chae JS; Park J
    Vector Borne Zoonotic Dis; 2009 Dec; 9(6):681-6. PubMed ID: 19271995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piroplasma infection in dogs in northern Spain.
    García AT
    Vet Parasitol; 2006 May; 138(1-2):97-102. PubMed ID: 16513282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Azithromycin and Compounded Atovaquone for Treatment of Babesia gibsoni in Dogs.
    Kirk SK; Levy JK; Crawford PC
    J Vet Intern Med; 2017 Jul; 31(4):1108-1112. PubMed ID: 28625019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in vitro interactions and in vivo efficacy of atovaquone and proguanil against Babesia gibsoni infection in dogs.
    Iguchi A; Matsuu A; Fujii Y; Ikadai H; Hikasa Y
    Vet Parasitol; 2013 Nov; 197(3-4):527-33. PubMed ID: 24075418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Importance of PCR for the diagnostics of canine babesiosis].
    Schaarschmidt D; Trächsel M; Achermann R; Hartelt K; Oehme R; Müller W
    Schweiz Arch Tierheilkd; 2006 Dec; 148(12):633-40. PubMed ID: 17263080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence survey of Babesia gibsoni infection and tick species in dogs in East China.
    Cao J; Yang Q; Zhang J; Zhou Y; Zhang H; Gong H; Zhou J
    Vet Parasitol; 2015 Nov; 214(1-2):12-5. PubMed ID: 26483164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy assessment of pentamidine isethionate and diminazene aceturate in the chemotherapy of Trypanosoma brucei brucei infection in dogs.
    Akpa PO; Ezeokonkwo RC; Eze CA; Anene BM
    Vet Parasitol; 2008 Feb; 151(2-4):139-49. PubMed ID: 18155842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro.
    Matsuu A; Koshida Y; Kawahara M; Inoue K; Ikadai H; Hikasa Y; Okano S; Higuchi S
    Vet Parasitol; 2004 Sep; 124(1-2):9-18. PubMed ID: 15350657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Babesia gibsoni genotype Asia in dogs from Brazil.
    Trapp SM; Messick JB; Vidotto O; Jojima FS; de Morais HS
    Vet Parasitol; 2006 Oct; 141(1-2):177-80. PubMed ID: 16765518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of canine babesiosis: the European perspective.
    Solano-Gallego L; Sainz Á; Roura X; Estrada-Peña A; Miró G
    Parasit Vectors; 2016 Jun; 9(1):336. PubMed ID: 27289223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autochthonous canine babesiosis in The Netherlands.
    Matjila TP; Nijhof AM; Taoufik A; Houwers D; Teske E; Penzhorn BL; de Lange T; Jongejan F
    Vet Parasitol; 2005 Jul; 131(1-2):23-9. PubMed ID: 15923085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymerase chain reaction confirmation of Babesia canis canis and Anaplasma phagocytophilum in dogs suspected of babesiosis in Slovakia.
    Majláthová V; Majláth I; Víchová B; Gul'ová I; Derdáková M; Sesztáková E; Pet'ko B
    Vector Borne Zoonotic Dis; 2011 Nov; 11(11):1447-51. PubMed ID: 21736486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sterilisation of Babesia canis infections by imidocarb alone or in combination with diminazene.
    Penzhorn BL; Lewis BD; de Waal DT; López Rebollar LM
    J S Afr Vet Assoc; 1995 Sep; 66(3):157-9. PubMed ID: 8596187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo safety and efficacy studies of amphotericin B on Babesia gibsoni.
    Yamasaki M; Harada E; Tamura Y; Lim SY; Ohsuga T; Yokoyama N; Morishita K; Nakamura K; Ohta H; Takiguchi M
    Vet Parasitol; 2014 Oct; 205(3-4):424-33. PubMed ID: 25260334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.